96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

30 trials found

diseases per page:

Showing 1 to 10 of 30 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05509777 (ClinicalTrials.gov)	August 1, 2023	19/8/2022	A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease (AMAY)	A Phase 3, Multicenter, Randomized Clinical Study to Evaluate Mirikizumabin Pediatric Crohn's Diseas ...	Crohn's Disease	Drug: Mirikizumab	Eli Lilly and Company	NULL	Not yet recruiting	2 Years	17 Years	All	90	Phase 3	NULL
2	EUCTR2019-002687-27-DK (EUCTR)	08/04/2022	08/11/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
3	EUCTR2019-002687-27-HR (EUCTR)	10/03/2022	14/03/2022	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
4	EUCTR2019-002687-27-LT (EUCTR)	03/09/2021	29/06/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
5	JPRN-jRCT2031210210	16/08/2021	28/07/2021	A Study of Mirikizumab(LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disea ...	A master protocol for a Phase 3, multicenter, open-label, long-term extension study to evaluate the ...	Ulcerative Colitis / Crohn's Disease -	Drug: Mirikizumab Administered SC Other Name: LY3074828	Yoshimoto Yusuke	NULL	Recruiting	Not applicable	Not applicable	Both	5	Phase 3	United States;Japan
6	EUCTR2019-002687-27-DE (EUCTR)	27/07/2021	13/04/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
7	EUCTR2019-002687-27-LV (EUCTR)	17/06/2021	11/03/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	France;Australia;Denmark;Netherlands;Latvia;China;Korea, Republic of;Czechia;Turkey;Lithuania;Austri ...
8	EUCTR2019-002687-27-FR (EUCTR)	10/06/2021	04/05/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
9	NCT04844606 (ClinicalTrials.gov)	May 26, 2021	12/4/2021	A Master Protocol (AMAZ): A Study of Mirikizumab(LY3074828) in Pediatric Participants With Ulcerativ ...	A Master Protocol for a Phase 3, Multicenter, Open-label, Long-term Extension Study to Evaluate the ...	Ulcerative Colitis;Ulcerative Colitis Chronic;Inflammatory Bowel Diseases;Crohn's Disease	Drug: Mirikizumab	Eli Lilly and Company	NULL	Recruiting	2 Years	19 Years	All	150	Phase 3	Israel;Italy;Japan;United States;Korea, Republic of;Poland
10	EUCTR2019-002687-27-IT (EUCTR)	18/05/2021	30/07/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Product Name: MIRIKIZUMAB Product Code: [LY3074828] INN or Proposed INN: MIRIKIZUMAB Product Name: MIRI ...	ELI LILLY & COMPANY, LILLY CORPORATE CENTER	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India;France ...

First Previous1 2 3Next Last